The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

Mon, 25th Sep 2023 07:43

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Shares in embattled Chinese property developer Evergrande plummeted Monday following the announcement that it would be unable to carry out a restructuring plan intended to guarantee its survival.

The company's shares collapsed more than 25% in Hong Kong by the break, trading at around HKD0.42 per share, underscoring market concerns as China's property sector faces an unprecedented crisis.

On Sunday evening, Evergrande announced that it was unable to issue new debt as its subsidiary, Hengda Real Estate Group, "is being investigated".

Evergrande's enormous debt has contributed to the country's deepening property market crisis, raising fears of a global spillover.

In early UK corporate news, Entain said that its online net gaming revenue has been softer than anticipated during the third quarter and Aviva announced it has acquired American International Group's UK protection business for GBP460 million.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 20.81 points, or 0.3%, at 7,663.10

----------

Hang Seng: down 1.6% at 17,760.95

Nikkei 225: closed up 0.9% at 32,678.62

S&P/ASX 200: closed up 0.1% at 7,076.50

----------

DJIA: closed down 106.58 points, 0.3%, at 33,963.84

S&P 500: closed down 0.2% at 4,320.06

Nasdaq Composite: closed down 0.1% at 13,211.81

----------

EUR: lower at USD1.0646 (USD1.0664)

GBP: lower at USD1.2238 (USD1.2267)

USD: higher at JPY148.36 (JPY148.22)

Gold: lower at USD1,921.05 per ounce (USD1,927.93)

(Brent): flat at USD92.31 a barrel (USD92.32)

(changes since previous London equities close)

----------

ECONOMICS

----------

Monday's key economic events still to come:

10:00 CEST Germany Ifo business climate index

09:00 CEST Spain PPI

11:00 BST UK CBI distributive trades survey

08:30 EDT US Chicago Fed national activity index

----------

Russia launched a major aerial attack on southern Ukraine overnight, the Ukrainian military said Monday, hitting Odesa port and destroying grain stores. Russia "attacked the south of the country again", the Defence Forces of the South of Ukraine said on the messaging platform Telegram. Since July when Moscow pulled out of a UN-brokered deal allowing safe grain shipments via the Black Sea, Russia has ramped up attacks on Ukraine's grain-exporting infrastructure in the southern Odesa and Mykolaiv regions.

----------

BROKER RATING CHANGES

----------

Jefferies raises AstraZeneca to 'buy' (hold) - price target 13,000 (10,500) pence

----------

RBC raises Derwent London to 'sector perform' (underperform) - price target 2,100 pence

----------

JPMorgan raises Close Brothers to 'neutral' (underweight) - price target 940 pence

----------

COMPANIES - FTSE 100

----------

GSK announced that the Japanese Ministry of Health, Labour & Welfare has approved Arexvy, a vaccine for the prevention of respiratory syncytial virus, for adults 60 years of age and above. This is the first time an RSV vaccine for older adults has been approved in Japan, the pharmaceutical company said. The approval has been granted based on data from the pivotal AReSVi-006 phase III vaccine efficacy trial.

----------

Entain said that its online net gaming revenue has been softer than anticipated during the third quarter of the year amid slower-than-expected growth in Australia and Italy, regulatory headwinds and adverse sporting results impacting margins. As a result, online NGR is expected to be up by a high single-digit percentage in the third quarter and up by a low double-digit percentage in the year as a whole. The sports betting, gaming and interactive entertainment reiterated its expectation for full-year earnings before interest, tax, depreciation and amortisation to be within the range of GBP1.0 billion and GBP1.05 billion, however.

----------

CRH confirmed its primary listing has now transferred to the New York Stock Exchange following approval from the Irish High Court. The company's shares on the London Stock Exchange now move to a standard listing from a standard listing. Separately, the company announced that it has entered into agreements with Merrill Lynch International and BofA Securities to repurchase up to USD1 billion of its shares on the LSE and/or in the US. This is USD1 billion tranche is the third stage of a wider USD3 billion buyback announced back in March.

----------

Aviva announced the acquisition of AIG Life from Corebridge Financial, a subsidiary of American International Group, for GBP460 million. The insurer said AIG Life UK provides a full suite of individual and group protection products, with 1.3 million individual protection customers and 1.4 million group protection members. "This acquisition brings significant strategic and financial benefits to Aviva. It strengthens our prospects in the highly attractive UK protection market and continues our progress in repositioning the group towards capital-light growth," said Chief Executive Amanda Blanc.

----------

COMPANIES - FTSE 250

----------

Pantheon International announced that it intends to begin a tender offer, which will be conducted as a reverse auction, for up to GBP150 million in value. Price levels for the tender offer range from 280 pence to 315p and it will close on October 17. Pantheon explained that it believes the tender offer represents an effective way for the company to invest in its own portfolio "at scale".

----------

OTHER COMPANIES

----------

Alphawave IP Group reported it had swung to a pretax loss in the first half of 2023 but nonetheless kept its full-year outlook unchanged as it predicted increased profitability in the second half of the year. The company swung to a pretax loss of USD11.2 million in the first half of 2023 from a profit of USD22.2 million the year prior. The loss came as Alphawave's cost of sales surged to USD104.7 million from just USD1.8 million and its research & development costs climbed to USD35.5 million from USD25.2 million. More positively, the company's interim revenue jumped to USD187.2 million from USD57.1 million thanks, in part, to the contribution of OpenFive. Looking forward, Alphawave reiterated its full-year outlook which sees revenue between USD340 million and USD360 million and adjusted earnings before interest, tax, depreciation and amortisation of around USD87 million.

----------

Boku announced that its Malaysian entity, Boku Network Services MY, has received authorisation from Bank Negara Malaysia to operate as a non-bank merchant acquirer. The approval follows continued investment by the company in the Malaysian market over many years, the mobile payment solution provider said. Boku MY's authorisation will permit Malaysian merchants to access the wider Boku payments network covering over 200 payment methods around the world.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.